Andrew Kompa

Apoptosis signal-regulating kinase 1 inhibition reverses deleterious indoxyl sulfate-mediated endothelial effects.

Feby Savira, Andrew R Kompa, Ruth Magaye, Xin Xiong, Li Huang, Beat M Jucker, Robert N Willette, Darren J Kelly, Bing H Wang

Journal article  |  2021  |  Life Sciences

AIMS: Indoxyl sulfate (IS), a protein-bound uremic toxin, is implicated in endothelial dysfunction, which contributes to adverse c..

The Preventable Productivity Burden of Kidney Disease in Australia.

Feby Savira, Zanfina Ademi, Bing H Wang, Andrew R Kompa, Alice J Owen, Danny Liew, Ella Zomer

Journal article  |  2021  |  Journal of the American Society of Nephrology

BACKGROUND: Kidney disease is associated with impaired work productivity. However, the collective effect of missed work days, redu..

RE: Blockade of apoptosis signal-regulating kinase 1 ameliorates cardiac dysfunction in cardiorenal syndrome via enhancing angiogenesis

Feby Savira, Andrew R Kompa, Amanda J Edgley, Beat M Jucker, Robert N Willette, Darren J Kelly, Bing H Wang

Journal article  |  2021  |  International Journal of Cardiology

Sustained subcutaneous delivery of secretome of human cardiac stem cells promotes cardiac repair following myocardial infarction.

Andrew R Kompa, David W Greening, Anne M Kong, Paul J McMillan, Haoyun Fang, Ritika Saxena, Raymond CB Wong, Jarmon G Lees, Priyadharshini Sivakumaran, Andrew E Newcomb, Bakhos A Tannous, Cameron Kos, Lina Mariana, Thomas Loudovaris, Derek J Hausenloy, Shiang Y Lim

Journal article  |  2021  |  Cardiovascular Research

AIMS: To establish pre-clinical proof of concept that sustained subcutaneous delivery of the secretome of human cardiac stem cells..

RE: Inhibition of apoptosis signal-regulating kinase 1 might be a novel therapeutic target in the treatment of cardiorenal syndrome

Feby Savira, Amanda J Edgley, Beat M Jucker, Robert N Willette, Henry Krum, Darren J Kelly, Andrew R Kompa, Bing H Wang

Journal article  |  2021  |  International Journal of Cardiology

Cost-effectiveness of dapagliflozin in chronic heart failure: an analysis from the Australian healthcare perspective

F Savira, BH Wang, AR Kompa, Z Ademi, A Owen, A Tonkin, S Zoungas, D Liew, E Zomer

Conference Proceedings  |  2020  |  EUROPEAN HEART JOURNAL

The impact of coronary heart disease on productivity in Australia over ten years

F Savira, BH Wang, AR Kompa, Z Ademi, A Owen, D Liew, E Zomer

Conference Proceedings  |  2020  |  EUROPEAN HEART JOURNAL

RE: ASK1, a new target in treating cardiorenal syndrome (CRS)

Feby Savira, Andrew R Kompa, Amanda J Edgley, Beat M Jucker, Robert N Willette, Darren J Kelly, Bing H Wang

Journal article  |  2020  |  International Journal of Cardiology

The impact of coronary heart disease prevention on work productivity: a 10-year analysis.

Feby Savira, Bing H Wang, Andrew R Kompa, Zanfina Ademi, Alice J Owen, Danny Liew, Ella Zomer

Journal article  |  2020  |  European Journal of Preventive Cardiology

AIMS: To determine the impact of preventing new (incident) cases of coronary heart disease (CHD) on years of life and productivity..

Cost-effectiveness of dapagliflozin in chronic heart failure: an analysis from the Australian healthcare perspective

Feby Savira, Bing H Wang, Andrew R Kompa, Zanfina Ademi, Alice J Owen, Sophia Zoungas, Andrew Tonkin, Danny Liew, Ella Zomer

Journal article  |  2020  |  European Journal of Preventive Cardiology

AIM: To assess the cost-effectiveness of dapagliflozin in addition to standard care versus standard care alone in patients with ch..